Literature DB >> 14516208

Recombinant perchloric acid-soluble protein suppresses the immunoglobulin production of human-human hybridoma HB4C5 cells.

Hiroaki Kanouchi1, Aya Matsuo, Tatsuzo Oka, Hirofumi Tachibana, Koji Yamada.   

Abstract

Because perchloric acid-soluble protein (PSP) has been conserved evolutionally in various species from Escherichia coli to humans, it may reflect an involvement in basic cellular regulation. However, the precise function of PSP is currently unknown. In this study, we examined the direct effect of PSP on the production of immunoglobulin (Ig) using human B, HB4C5, NAT-30, and U266 cells because it has been reported that subcutaneous administration of PSP affects rodent immune systems. Suppression of Ig productivity and decrement of the cell viability was recognized only in HB4C5 cells by the addition of PSP into the medium. On the other hand, PSP had no effect on Ig productivity and cell viability in NAT-30 and U266 cells. In addition, PSP was clearly incorporated by HB4C5 but not by the other cells. These results suggest that the Ig production suppressed by PSP, which has been previously reported to inhibit protein synthesis, contributed to the incorporation of PSP into the HB4C5 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516208     DOI: 10.1290/1543-706X(2003)039<0263:RPAPST>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  18 in total

1.  A role for a highly conserved protein of unknown function in regulation of Bacillus subtilis purA by the purine repressor.

Authors:  P Rappu; B S Shin; H Zalkin; P Mäntsälä
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

2.  Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases.

Authors:  A E Panerai; P Sacerdote; M Bianchi; F Nicoletti; B Manfredi; L Gaspani; A Bartorelli; F Ceciliani; S Ronchi
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

3.  Complex metabolic phenotypes caused by a mutation in yjgF, encoding a member of the highly conserved YER057c/YjgF family of proteins.

Authors:  J L Enos-Berlage; M J Langendorf; D M Downs
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

4.  Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114.

Authors:  S Racca; F Di Carlo; A Bartorelli; B Bussolati; G Bussolati
Journal:  Virchows Arch       Date:  1997-11       Impact factor: 4.064

5.  Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

Authors:  H Murakami; H Masui; G H Sato; N Sueoka; T P Chow; T Kano-Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  Ribonuclease activity of rat liver perchloric acid-soluble protein, a potent inhibitor of protein synthesis.

Authors:  R Morishita; A Kawagoshi; T Sawasaki; K Madin; T Ogasawara; T Oka; Y Endo
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

7.  Identification of a 220-kDa membrane tumor-associated antigen by human anti-UK114 monoclonal antibodies selected from the immunoglobulin repertoire of a cancer patient.

Authors:  A Funaro; A L Horenstein; G Ghisolfi; B Bussolati; A Bartorelli; G Bussolati
Journal:  Exp Cell Res       Date:  1999-03-15       Impact factor: 3.905

8.  Production of functional rat liver PSP protein in Escherichia coli.

Authors:  T Oka; Y Nishimoto; T Sasagawa; H Kanouchi; Y Kawasaki; Y Natori
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

9.  Enhancement of immunoglobulin productivity of human-human hybridoma HB4C5 cells by basic proteins and poly-basic amino acids.

Authors:  T Sugahara; T Sasaki; H Murakami
Journal:  Biosci Biotechnol Biochem       Date:  1994-12       Impact factor: 2.043

10.  Perchloric acid-soluble proteins from goat liver inhibit chemical carcinogenesis of Syrian hamster cheek-pouch carcinoma.

Authors:  F Ghezzo; G N Berta; B Bussolati; A Bosio; G Corvetti; F Di Carlo; G Bussolati; R Guglielmone; A Bartorelli
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.